DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in DiaMedica Therapeutics Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +3 vs. Q3 2023
- Shares held
- 3.84M
- −240.0K (−5.9%) vs. Q3 2023
- Total value
- $10.9M
- +$380.5K (+3.6%) vs. Q3 2023
- New holders
- 6
- 12 more added
- Sold out
- 3
- 4 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 88 | $87.8M |
| Q1 2026 | 99 | $79.2M |
| Q4 2025 | 92 | $96.0M |
| Q3 2025 | 78 | $82.8M |
| Q2 2025 | 58 | $34.2M |
| Q1 2025 | 57 | $28.5M |
| Q4 2024 | 45 | $36.5M |
| Q3 2024 | 40 | $23.3M |
| Q2 2024 | 32 | $14.9M |
| Q1 2024 | 32 | $12.7M |
| Q4 2023 | 38 | $10.9M |
| Q3 2023 | 36 | $11.0M |
| Q2 2023 | 32 | $15.1M |
| Q1 2023 | 25 | $3.93M |
| Q4 2022 | 28 | $3.99M |
| Q3 2022 | 26 | $3.14M |
| Q2 2022 | 28 | $7.42M |
| Q1 2022 | 34 | $10.0M |
| Q4 2021 | 39 | $14.9M |
| Q3 2021 | 34 | $11.2M |
| Q2 2021 | 43 | $16.9M |
| Q1 2021 | 41 | $52.1M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding DiaMedica Therapeutics Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 15 | $43 | 0.00% | +15 | New |
| Toronto Dominion Bank | 24 | $68 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 172 | $488 | 0.00% | +9+5.5% | Added |
| Federation des caisses Desjardins du Quebec | 230 | $653 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 481 | $1.00K | 0.00% | −539−52.8% | Reduced |
| JPMorgan Chase & Co | 564 | $1.60K | 0.00% | +539+2,156.0% | Added |
| Advisor Group Holdings, Inc. | 1,000 | $2.84K | 0.00% | 00.0% | Unchanged |
| Legend Financial Advisors, Inc. | 1,000 | $2.84K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,082 | $3.00K | 0.00% | +277+34.4% | Added |
| TD Waterhouse Canada Inc. | 1,070 | $4.05K | 0.00% | −500−31.8% | Reduced |
| Naples Money Management LLC | 3,878 | $11.0K | 0.01% | +3,878 | New |
| US Bancorp | 4,335 | $12.3K | 0.00% | 00.0% | Unchanged |
| Massmutual Trust Co FSB | 4,824 | $13.7K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 4,843 | $13.8K | 0.00% | +4,843 | New |
| Tower Research Capital LLC (TRC) | 7,264 | $20.6K | 0.00% | +3,503+93.1% | Added |
| Avantax Advisory Services, Inc. | 12,500 | $35.5K | 0.00% | +12,500 | New |
| Charles Schwab Investment Management Inc | 13,251 | $37.6K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 14,000 | $39.8K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 16,959 | $48.2K | 0.00% | 00.0% | Unchanged |
| Stonebridge Capital Advisors LLC | 20,000 | $56.8K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 22,715 | $64.5K | 0.00% | +6,847+43.1% | Added |
| Jane Street Group, LLC | 23,761 | $67.5K | 0.00% | +23,761 | New |
| Susquehanna International Group, LLP | 27,619 | $78.4K | 0.00% | +27,619 | New |
| Millennium Management LLC | 28,845 | $81.9K | 0.00% | +173+0.6% | Added |
| Bank of New York Mellon Corp | 34,233 | $97.2K | 0.00% | −384−1.1% | Reduced |
| Catalyst Financial Partners LLC | 36,267 | $103.0K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 66,629 | $189.2K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 104,732 | $297.4K | 0.00% | +3,007+3.0% | Added |
| Aristides Capital LLC | 106,333 | $302.0K | 0.15% | 00.0% | Unchanged |
| First Manhattan Co | 114,744 | $325.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 120,995 | $343.6K | 0.00% | +27,195+29.0% | Added |
| Northern Trust Corp | 133,633 | $379.5K | 0.00% | +43,933+49.0% | Added |
| Geode Capital Management, LLC | 218,778 | $621.5K | 0.00% | 00.0% | Unchanged |
| Bleichroeder LP | 222,317 | $631.4K | 0.14% | 00.0% | Unchanged |
| Altium Capital Management LP | 287,698 | $817.1K | 0.56% | −208,302−42.0% | Reduced |
| Paragon Associates & Paragon Associates II Joint Venture | 500,000 | $1.42M | 3.26% | +30,000+6.4% | Added |
| Vanguard Group Inc | 802,171 | $2.28M | 0.00% | +13,382+1.7% | Added |
| Cooperman Leon G | 883,623 | $2.51M | 0.12% | +7,630+0.9% | Added |
| EAM Investors, LLC | 0 | $0 | 0.00% | −212,512−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −26,745−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| Jacob Asset Management of New York LLC | – | – | – | – | Not filed |